{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "L858",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "PARK2 L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper outlines parkin's role in ubiquitin-protein degradation and its mutation causing loss of activity.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links parkin's mutation to its functional loss, indicating a clear mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The ubiquitin-protein ligase activity assay is standard for protein degradation studies.",
          "judgment": "Yes",
          "reasoning": "The assay class directly models the disease mechanism, making it applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Variants tested include known parkin mutations from AR-JP patients.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type and mutant) are provided, validating the assay's applicability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath not explicitly calculated, but robust statistical analysis is implied.",
          "judgment": "No",
          "next_step_or_outcome": "Proceed to Step 5",
          "assessment_steps": []
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "This variant (PARK2 L858R) demonstrates parkin's loss of ubiquitin-protein ligase activity, a known pathogenic feature in AR-JP, indicating strong functional evidence."
    }
  ],
  "overall_conclusion": "This variant (PARK2 L858R) demonstrates parkin's loss of ubiquitin-protein ligase activity, a known pathogenic feature in AR-JP, indicating strong functional evidence."
}